2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | 79.839 | 111.778 | 124.664 | 127.070 | 148.590 | 170.405 | 207.495 | 248.209 | 341.942 | 297.015 |
Total Income - EUR | 80.248 | 111.780 | 124.664 | 127.464 | 148.590 | 170.405 | 207.909 | 249.015 | 345.041 | 299.815 |
Total Expenses - EUR | 68.248 | 107.174 | 125.406 | 139.291 | 106.274 | 142.831 | 152.065 | 206.415 | 245.567 | 245.952 |
Gross Profit/Loss - EUR | 12.000 | 4.606 | -742 | -11.827 | 42.316 | 27.574 | 55.844 | 42.599 | 99.474 | 53.863 |
Net Profit/Loss - EUR | 10.190 | 3.296 | -822 | -17.977 | 40.909 | 25.870 | 53.873 | 40.278 | 96.992 | 51.588 |
Employees | 6 | 8 | 10 | 9 | 7 | 7 | 7 | 7 | 7 | 6 |
Check the financial reports for the company - Endemedica Srl
2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | 18.274 | 17.389 | 15.486 | 11.745 | 24.191 | 24.668 | 13.293 | 9.645 | 37.007 | 29.098 |
Current Assets | 29.468 | 30.359 | 44.033 | 22.894 | 68.697 | 53.140 | 88.603 | 84.570 | 104.707 | 70.183 |
Inventories | 1.368 | 3.480 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Receivables | 3.295 | 9.452 | 18.507 | 14.716 | 36.270 | 33.924 | 65.690 | 18.970 | 85.308 | 60.115 |
Cash | 24.804 | 17.427 | 25.527 | 8.178 | 32.427 | 19.216 | 22.912 | 65.601 | 19.400 | 10.069 |
Shareholders Funds | 9.278 | 12.651 | -778 | -18.959 | 25.902 | 25.919 | 53.921 | 40.325 | 97.048 | 51.644 |
Social Capital | 45 | 45 | 45 | 44 | 45 | 48 | 48 | 46 | 47 | 46 |
Debts | 40.438 | 35.097 | 60.297 | 53.598 | 66.986 | 52.017 | 47.975 | 53.891 | 44.667 | 48.800 |
Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Exchange rate - RON | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 | 4.4821 |
Main CAEN | "8621 - 8621" | |||||||||
CAEN Financial Year |
8621
|
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Comments - Endemedica Srl